ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 53 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,919 | -12.8% | 6,396 | +0.2% | 0.00% | – |
| Q2 2023 | $2,201 | -55.9% | 6,381 | +0.4% | 0.00% | – |
| Q1 2023 | $4,991 | -21.3% | 6,358 | +0.2% | 0.00% | – |
| Q4 2022 | $6,345 | +26.9% | 6,345 | +0.4% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 6,318 | +0.3% | 0.00% | – |
| Q2 2022 | $7,000 | -93.7% | 6,301 | -92.1% | 0.00% | – |
| Q1 2022 | $111,000 | -68.0% | 80,189 | -47.4% | 0.00% | – |
| Q4 2021 | $347,000 | -73.8% | 152,560 | -52.0% | 0.00% | – |
| Q3 2021 | $1,324,000 | +182.3% | 317,601 | +221.9% | 0.00% | – |
| Q2 2021 | $469,000 | +801.9% | 98,676 | +1472.5% | 0.00% | – |
| Q1 2021 | $52,000 | +100.0% | 6,275 | +21.8% | 0.00% | – |
| Q4 2020 | $26,000 | – | 5,150 | +7703.0% | 0.00% | – |
| Q3 2020 | $0 | – | 66 | +8.2% | 0.00% | – |
| Q2 2020 | $0 | – | 61 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 61 | +74.3% | 0.00% | – |
| Q2 2019 | $0 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,710,000 | 0.88% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $570,000 | 0.49% |
| Parkman Healthcare Partners LLC | 415,384 | $1,973,000 | 0.43% |
| Altium Capital Management LP | 172,218 | $818,000 | 0.19% |
| Vigilare Wealth Management | 52,535 | $250,000 | 0.15% |
| BRIGHTON JONES LLC | 332,875 | $1,581,000 | 0.08% |
| Ikarian Capital, LLC | 200,204 | $950,000 | 0.08% |
| IPG Investment Advisors LLC | 31,106 | $147,754,000 | 0.04% |
| DOWLING & YAHNKE LLC | 150,464 | $715,000 | 0.04% |
| Jump Financial, LLC | 58,225 | $276,000 | 0.03% |